1. Identity of the issuer or the underlying issuer |
Assura Group Limited |
|||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||||||||||||||
An acquisition or disposal of voting rights |
|
|||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||||||||||||||
An event changing the breakdown of voting rights |
|
|||||||||||||||
Other (please specify): |
Firm Placing and Open Offer Shares |
X |
||||||||||||||
3. Full name of person(s) subject to the |
Invesco Limited |
|||||||||||||||
4. Full name of shareholder(s) |
|
|||||||||||||||
5. Date of the transaction and date on |
17 February 2011 |
|||||||||||||||
6. Date on which issuer notified: |
18 February 2011 |
|||||||||||||||
7. Threshold(s) that is/are crossed or |
19%, 20%, 21% |
|||||||||||||||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
Ordinary 10p Shares |
62,402,596 |
62,402,596 |
|
|
72,636,506 |
|
21.18% |
|||||||||
GB0033732602 |
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
72,636,506 |
21.18% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||||||||||||||||
Bank of Ireland, Dublin - 381,407 Bank of New York - 55,076,640 Mellon Bank, Pittsburgh - 604,272 State Street Trust & Banking Co, London - 15,302,936 Northern Trust Company, London - 1,271,251
|
||||||||||||||||
|
||||||||||||||||
Proxy Voting: |
||||||||||||||||
10. Name of the proxy holder: |
|
|||||||||||||||
11. Number of voting rights proxy holder will cease |
|
|||||||||||||||
12. Date on which proxy holder will cease to hold |
|
|||||||||||||||
|
||||||||||||||||
|
|
|||||||||||||||
14. Contact name: |
Samantha Edwards |
|||||||||||||||
15. Contact telephone number: |
01491 416381 |
|||||||||||||||
Note: Annex should only be submitted to the FSA not the issuer |
||||||||||||||||
Annex: Notification of major interests in share |
||||||||||||||||
|
||||||||||||||||
A: Identity of the persons or legal entity subject to the notification obligation |
||||||||||||||||
Full name (including legal form of legal entities)
|
|
|||||||||||||||
Contact address (registered office for legal entities)
|
|
|||||||||||||||
Phone number & email
|
|
|||||||||||||||
Other useful information (at least legal representative for legal persons)
|
|
|||||||||||||||
|
|
|||||||||||||||
B: Identity of the notifier, if applicable |
||||||||||||||||
Full name
|
Invesco Limited |
|||||||||||||||
Contact address
|
Registered address: 30 Finsbury Square, London, EC2A 1AG |
|||||||||||||||
Phone number & email
|
020 7638 0731 |
|||||||||||||||
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
|||||||||||||||
|
||||||||||||||||
C: Additional information |
||||||||||||||||
|
||||||||||||||||
For notes on how to complete form TR-1 please see the FSA website. |
||||||||||||||||